A method of modulating the plasma {TAIL ~ half life} of anti glypican 3 antibody, a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody that has a plasma half life that has been modulated, {HEAD ~ a method} of preparing the anti glypican 3 antibody and a pharmaceutical composition comprising the anti glypican 3 antibody as an active ingredient are provided 
A method of modulating the plasma { TAIL ~ half life } of anti glypican 3 antibody , a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody that has a plasma half life that has been modulated , { HEAD ~ a method } of preparing the anti glypican 3 antibody and a pharmaceutical composition comprising the anti glypican 3 antibody as an active ingredient are provided
OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH